| 1 |
33776565 | FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients. | 2021 Mar 12 |
1 |
| 2 |
34300255 | Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism. | 2021 Jul 13 |
1 |
| 3 |
31942755 | Plasma Fibroblast Growth Factor 23 Concentration Is Associated with Intracranial Cerebral Atherosclerosis in Acute Ischemic Stroke Patients. | 2020 Jan |
2 |
| 4 |
32386861 | The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients. | 2020 Dec |
4 |
| 5 |
33185993 | The metabolic, neuroprotective cardioprotective and antitumor effects of the Klotho protein. | 2020 Sep |
1 |
| 6 |
25583093 | Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population? | 2015 Apr |
2 |
| 7 |
24111496 | Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism. | 2014 Apr |
2 |
| 8 |
23413976 | Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study. | 2013 Feb 17 |
1 |
| 9 |
23490272 | Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients. | 2013 Oct |
1 |
| 10 |
24039882 | Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients. | 2013 |
1 |
| 11 |
22554017 | Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation. | 2012 Aug |
1 |
| 12 |
23214203 | Fibroblast growth factor 23--structure, function and role in kidney diseases. | 2012 May-Jun |
1 |
| 13 |
21733911 | The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. | 2011 Nov |
1 |
| 14 |
22010474 | [Fibroblast growth factor-23 (FGF-23). Part II. Significance in chronic kidney disease]. | 2011 |
1 |
| 15 |
22164160 | The serum level of fibroblast growth factor-23 and calcium-phosphate homeostasis in obese perimenopausal women. | 2011 |
1 |
| 16 |
22335012 | [Fibroblast growth factor-23 (FGF-23). Part III. Relationship between FGF-23 serum concentration and cardio-vascular morbidity and mortality]. | 2011 |
1 |
| 17 |
20376517 | The relationship between circulating fibroblast growth factor 23 and bone metabolism factors in Korean hemodialysis patients. | 2010 Jun |
2 |
| 18 |
21234310 | Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease. | 2010 Dec 30 |
1 |
| 19 |
19188744 | Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. | 2009 |
1 |
| 20 |
19946326 | Clinical relevance of FGF-23 in chronic kidney disease. | 2009 Dec |
2 |
| 21 |
18791804 | Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. | 2008 |
1 |
| 22 |
15086938 | FGF-23 in patients with end-stage renal disease on hemodialysis. | 2004 May |
1 |